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Abstract: Measurements of Cherenkov emission in tissue during radiation
therapy are shown to enable estimation of hemoglobin oxygen saturation
non-invasively, through spectral fitting of the spontaneous emissions from
the treated tissue. Tissue oxygenation plays a critical role in the efficacy of
radiation therapy to kill tumor tissue. Yet in-vivo measurement of this has
remained elusive in routine use because of the complexity of oxygen
measurement techniques. There is a spectrally broad emission of Cherenkov
light that is induced during the time of irradiation, and as this travels
through tissue from the point of the radiation deposition, the tissue
absorption and scatter impart spectral changes. These changes can be
quantified by diffuse spectral fitting of the signal. Thus Cherenkov emission
spectroscopy is demonstrated for the first time quantitatively in vitro and
qualitatively in vivo, and has potential for real-time online tracking of tissue
oxygen during radiation therapy when fully characterized and developed.
©2012 Optical Society of America
OCIS codes: (170.1470) Blood or tissue constituent monitoring; (170.3660) Light propagation
in tissues; (170.6510) Spectroscopy, tissue diagnostics; (170.6280) Spectroscopy, fluorescence
and luminescence.
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1. Introduction
Recently it was demonstrated that Cherenkov emission is induced by MeV photons or
electrons from a linear accelerator and detectable using a CMOS camera [1]. In particular, the
blue-dominated spectral emission could excite an embedded fluorophore such as
protoporphyrin IX which is known to be present at increased levels in tumors. The optical
Cherenkov signal is induced when highly energetic charged particles travel through a
dispersive medium like tissue. Based on this origin of contrast several reports have also
shown the ability to image radioisotopes in vitro as well as in vivo [2–5]. Although optical
Cherenkov emission is strongest in the blue, the broad band characteristics is well known with
an intensity spectrum proportional to ~ 1 λ 3 , or the number of photons per wavelength is
proportional to ~ 1 λ 2 [6]. As this light propagates through tissue it will be affected by the
oxygenated and deoxygenated hemoglobin as well as other chromophores. The difference in
absorption between the hemoglobin chromophores is routinely used in NIR spectroscopy for
tissue oxygenation assessments.
Tissue oxygenation plays a critical role in the efficacy of radiation therapy to kill tumor
tissue [7]. Inadequate oxygen supply in tumor tissue (i.e. hypoxic areas) may lead to treatment
failure through insufficient DNA damage in the tumor [8], and several clinical and pre-
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clinical studies have shown that oxygenation monitoring is a prognostic factor in radiation
therapy [8, 9]. Multi-center clinical studies have shown that pre-treatment tissue oxygen
pressure (pO2) is predictive of outcome in head and neck cancers [10], and other studies have
shown that the pO2 increases during the course of fractionated external beam radiation therapy
[11], and that this change is correlated to effective local control. Optical hemoglobin
spectroscopy has been used in-vivo, to show that oxygen hemoglobin saturation increases
during fractionated radiation therapy in a rodent tumor model [12].
In this work, we show how oxygen saturation spectroscopy is achieved in-vivo and
noninvasively, simply by measurement and spectral fitting of the endogenously emitted
Cherenkov emission signal, as altered by absorption as it leaves the tissue or origin. A method
is presented that relies on the spectral fitting of a theoretical light transport model to the
Cherenkov emission spectrum. This study is the first presentation of this spectral signature,
and will be followed by quantitative validation in further animal studies. By quantifying the
absorption of the emitted photons coming from tissue chromophores, the hemoglobin oxygen
saturation can be estimated. This is the first spectroscopic application of Cherenkov emission
spectroscopy (CES) providing real-time physiological information about the tissue
undergoing external beam radiation therapy.
2. Materials and methods
2.1 External beam radiation and experimental setup
All experiments were performed with a linear accelerator (Varian Clinac 2100C, Varian
Medical Systems, Palo Alto, USA). A circular beam shape with 30 mm diameter or a semicircular beam shape with 24 mm diameter was used. Electron beams were used in all
experiments with an approximate dose rate of 4Gy/min. The setup is shown schematically in
Fig. 1(a). The fiber-bundle was positioned at 90° with respect to the external beam direction
in order to minimize the Cherenkov emission induced directly in the fiber material [13].
Measurements of Cherenkov spectra were all taken while the radiation beam was directly
hitting the phantoms or tissues.
2.2 Mathematical model of external beam induced Cherenkov emission
Cherenkov emission is induced when electrons with a kinetic energy above 0.219 MeV
propagate through a dispersive medium [14, 15]. The number of emitted Cherenkov photons,
denoted N ( λ , E ) , within a spectral interval [ λ − ∆λ , λ + ∆λ ] due to an electron with kinetic
energy E propagating a distance dx is given by the Frank-Tamm formula [16], i.e.


 dx
(1)


In Eq. (1), n is the refractive index of the medium, assumed to be 1.33 for water and 1.4
for soft tissue, and β ( E ) is the velocity of the electron relative to the speed of light and its
dN ( λ , E ) =

2π  1
1 
1
−

 1 −
137  λ − ∆λ λ + ∆λ   β ( E ) 2 n 2

energy dependence is given by [15]
1

2 2
 
 
 
 
1
β ( E ) = 1 − 
 
  E +1  
  0.511  



(2)

The number of Cherenkov photons emitted within the spectral interval 400-700 nm is
calculated using Eq. (1) and plotted in Fig. 1(b).
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Fig. 1. Experimental setup. (a) a schematics showing the setup where electron beam irradiates
from top of phantom. (b) the Frank-Tamm formula is plotted showing the number of photons
generated per mm and electron for varying energy. (c) electron range as a function of energy.
(d-f) electron beams at 6, 12 and 18 MeV irradiating a water tank. (g-i) electron beams
irradiating a scattering solution of saline and intralipid. (j-l) electron beams irradiating a
scattering phantom with added blood. (m) a schematic showing the optical point sources
distributed throughout the electron beam.

As the electron propagates through the medium its kinetic energy will dissipate through
inelastic collisions and according to the continuous slowing down approximation [17] the
energy decreases linearly with depth. Assuming that an electron travels on a straight path
from the surface given by the z-direction, the kinetic energy can be approximated by Harder’s
formula [17], i.e.


z 
.
E = E0 1 −
(3)
 R 
p 

Here E0 (MeV) is the electron’s incident energy at the surface and R p (mm) is the
practical range of the electrons here given by
R p = 4.612 × E0 + 3.074.

(4)

Equation (4) is retrieved from a linear fit to several data sources i.e [15], [17]. and [18],
specifying the most probable energy as a function of range. The data and linear fit is shown in
Fig. 1(c).
Since the photon yield, in Eq. (1), is dependent on the energy and the energy decreases
with depth, the number of emitted Cherenkov photons will change dependent on electron
propagation distance. The depth dependent Cherenkov photon yield is then given by inserting
Eq. (3) in Eq. (2) and defining

dN ( λ , E0 , z ) =
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where
1

2
 
 2
 
 
 
 
1
β ( E0 , z ) = 1 − 
(6)
  .
  E0 
z   
  0.511  1 − R  + 1  
p 

 
 
The energy (and depth) dependence of the Cherenkov emission is demonstrated in the
photographs in Fig. 1(d)-(f) where a water tank was irradiated from the top by 6, 12 and 18
MeV-electron beams.
During external beam radiation therapy, Cherenkov emission is generated in tissue hence
the optical photons are subject to strong scattering and absorption. The effect of optical
scattering on the Cherenkov emission is seen in Fig. 1(g)-(i) while the color-change seen in
Fig. 1(j)-(l) indicates the presence of a spectrally dependent absorber, in this case 0.2%
porcine blood added to the phantom. In this study we assume the simplest approach and adopt
the Green’s solution to the diffusion equation in order to describe the photon migration from
the point of Cherenkov generation to the fiber bundle where the light is collected. However,
as has been discussed above the Cherenkov emission is induced throughout the extent of the
electron beam which is defined laterally by the beam shape and transversally by the electron
range. Thus, absorption spectra of hemoglobin change the Cherenkov spectra, however the
exact shape of the spectral distortion varies with beam profile and distance to the detecting
fiber, as well as the expected variation with hemoglobin concentration and oxygenation.
To model this effect, Eq. (5) defines the number of photons emitted at a specific depth. In
order to implement this in a forward numerical model, multiple point sources (~27000) are
positioned within the coordinates that defines the beam, seen schematically in Fig. 1(m). The
point source strength, or power, is given by Eq. (5), i.e. point sources placed deeper into the
medium irradiate slightly weaker. At the detector position, the contributions from all the point
sources are added. The detected intensity at one wavelength can then be evaluated by
M

I (λ ) = C∑
i =1

Where D = ( 3µ s ' )

´ −1

hc N ( λ , E0 , z )
exp ( − µeff Ri )
λ 4π DRi

(7)

and µeff = µ a D is the wavelength-dependent diffusion coefficient

and effective attenuation coefficient respectively. The constant C accounts for dose rate as
well as conversion between fluence rate and detector intensity. The summation is performed
for M sources and the distance between each point source and the detector is given by Ri ,
also shown schematically in Fig. 1(m).
In order to retrieve a simulated Cherenkov emission spectrum Eq. (7) is evaluated for
several wavelengths. For a given wavelength of interest, the waveband in Eq. (5) was chosen
to be λ ± 0.5 nm.
2.3 Spectral fitting to retrieve chromophore concentrations
The forward model presented above was used to extract the total hemoglobin concentration
and hemoglobin oxygen saturation by a fitting procedure. The measured spectra and the
calculated spectra were mean-normalized and compared within an iterative non-linear least
squares method using Matlab 7.10.0 (The MathWorks Inc., Natick, Massachusetts, USA).
Reduced scattering parameters were held constant within the fitting process and the
wavelength dependent scattering was given by

µ s '(λ ) = Aλ − b
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where A is the scatter amplitude, and b is the scatter power. Scatter amplitude and power for
the intralipid solutions were calculated from [19] while the mouse optical scattering
parameters were compiled from [20]. The absorption coefficient was defined by

µa (λ ) = cHbtot ×  SO2ε HbO (λ ) + (1 − SO2 ) ε Hb (λ )  + Cw µ H O (λ )
2

2

(9)

where cHbtot is the total hemoglobin concentration, is the oxygen saturation while ε HbO2 and

ε Hb is the extinction coefficient for oxy- and deoxy-hemoglobin respectively at wavelength λ
[21]. Cw is the water fraction, and µ H 2 O is the absorption coefficient of pure water at
wavelength λ [22].
In each iteration cHbtot and SO 2 were updated before evaluating Eq. (7), and fitting for
SO2 in Eq. (9) based upon the full spectrum of wavelengths measured, fitted simultaneously.
In the phantom experiments the method was calibrated using a scattering phantom with no
absorber while fitting for Cw only. This parameter was then fixed for the subsequent added
blood experiments and the deoxygenation experiments. In the in vivo experiments calibration
was performed using a euthanized animal assuming 0% oxygenation and 70% water fraction
in the tissue.
Commonly oxygenation of tissue is estimated by the partial pressure of oxygen, pO2,
rather than SO2. The relationship between pO2 and SO2 is non-linear and described by the
well known Hill saturation curve. While it is more informative to have direct measurement of
pO2, it is largely recognized that direct measurement of this is challenging, due to the
microscopic heterogeneity of pO2 change with distance from capillaries. Bulk tissue pO2 is
thought to vary at least monotonically with bulk SO2 when measured in tissue volumes
greater than a millimeter cubed, although related non-linearly by the Hill curve. In this work,
the tissue pO2 was not directly measured although it is known that tissue pO2 and SO2 are
both near zero within minutes of animal euthanasia, and normal tissue hemoglobin SO2 values
can be in the range of 50-70% saturated.
2.4 Phantom preparation
The scattering liquid phantoms used in the experiments were made of phosphate buffered
saline solution (D-PBS, Mediatech Inc, Manassas, VA), 0.2% v/v Intralipid© (Fresenius
Kabi, Uppsala, Sweden) and porcine whole blood. Concentrations of 0.2% blood were used in
most phantoms to mimic the expected concentration in murine skin. Prior to the experiments
the hemoglobin concentration was measured using a hemoglobin meter (Hb 201 + , Hemocue,
Ängelholm, Sweden). The oxygenation reference instrument was an ischemia monitoring
system (Spectros T-stat, Spectros, Portola Valley, CA). Yeast was added in order to alter the
oxygenation of the sample.
2.5 Animal handling
Four Balb/c mice were subject to external beam irradiation. Hair was removed by shaving the
flanks of the animals. The mice were anesthetized with a ketamine/xylazine mixture
administered intraperitoneally in a ratio of 90:10 mg/kg. Measurements were performed
before and 30 min after the mice were euthanized through cervical dislocation.
2.6 Spectrometer setup and data processing
The spectrometer setup was governed by a spectrograph (Acton Insight, Princeton
Instruments, Acton, USA) connected to a front illuminated CCD (Pixis 400F, Princeton
Instruments, Acton, USA). The CCD was cooled to −70°C and the grating used in all
experiments was 300 lines/mm. A 13 m long fiber bundle (Zlight, Latvia), composed of six
400 µm diameter silica fibers, collected the light at the phantom and guided the photons to the
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spectrometer. The fiber bundle tip was positioned in contact with phantom boundary at the top
surface of the liquid in the center of the beam. All spectra were acquired with an integration
time of 60 seconds. Each spectrum was subject to background subtraction, normalization with
integration time and binning by averaging four neighboring spectral bins. In all experiments
the Cherenkov emission induced in the fiber was acquired before each experiment, and
subtracted before data analysis.
2.7 Camera setup and image processing
Images were acquired with a CMOS camera Nikon D90 (Nikon, Tokyo, Japan) equipped with
a standard zoom lens Sigma EX 18-50/2.8 Macro HSM (Sigma Corporation, Kawasaki,
Japan). The integration time for all images was 30 seconds. Images were processed by
subtraction of a background image that was acquired in the same light conditions as when the
beam irradiation was executed.
3. Results
3.1 Optical phantom experiments of hemoglobin concentration
Phantoms, made of phosphate buffered saline solution (PBS), Intralipid© and porcine whole
blood, were irradiated using a circular shaped electron beam at 18 MeV. The concentration of
whole blood was changed and the spectra seen in Fig. 2(a) were obtained using the fibercoupled spectrometer during beam irradiation. By fitting the forward model to each spectrum
the total hemoglobin concentration was assessed and is shown in Fig. 2(b).

Fig. 2. Cherenkov emission spectroscopy of hemoglobin concentration. (a) Cherenkov
emission spectra from phantom solutions with varying concentrations of porcine blood,
indicated in the legend. (b) fitted values for the total hemoglobin concentration are offset
against the true values. The inset shows the retrieved oxygenation values.

The absolute values for the measured hemoglobin concentrations are within 25% of the
true concentrations. The inset in Fig. 2(b) shows the oxygen saturation, which on average is
93 +/− 4%. This value is in close agreement with the reference level of 92% that was acquired
from the phantom using the ischemia monitoring system, see Materials and methods section.
In Fig. 2(a) it is seen that the predominant change in the spectrum as a function of blood
concentration occurs at wavelengths shorter than approximately 630 nm.
3.2 Optical phantom experiments of oxygen saturation
In order to investigate whether this technique is able to detect changes in tissue oxygenation,
baking yeast was mixed into the scattering phantom containing blood. Measurements were
acquired during beam irradiation before and approximately 30 minutes after adding the yeast.
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Fig. 3. Cherenkov emission spectroscopy of tissue oxygenation. (a) spectra from a welloxygenated and a de-oxygenated scattering phantom solution are shown. The photos in (b) and
(c) depict the color-change in the well- and de-oxygenated phantoms respectively.

The spectra are seen in Fig. 3(a). A change in hemoglobin oxygen saturation will change
the spectral intensity and a shift towards blue wavelengths is expected. This is seen in the
photographs from the oxygenated phantom in Fig. 3(b) and the de-oxygenated phantom in
Fig. 3(c). By fitting the forward model to the two spectra, the retrieved tissue oxygenation
was 96% in the well-oxygenated case and 5% in the de-oxygenated case. From previous
experiments the ability to deoxygenate a solution with yeast has been confirmed multiple
times, and is a standard way to induce nearly 0% oxygen saturation in the phantom.
3.3 In vivo experiments of tissue oxygenation
In order to demonstrate the method in-vivo, four healthy Balb/c mice were subject to external
beam radiation on the hind flank. An electron beam at 18 MeV, shaped like a half-circle,
irradiated the flank of the animal, see Fig. 4(a). Irradiation was performed before and after
sacrifice, rendering one spectrum from oxygenated tissue and one spectrum from
deoxygenated tissue.

Fig. 4. Cherenkov emission spectroscopy of tissue oxygenation in vivo. (a) mouse positioned
in the target region with the beam profile delineated in red. (b) typical spectra from a mouse
pre and post euthanasia. (c) the results from the fitting procedure for both total hemoglobin
concentration (left y-axis) and oxygen saturation (right y-axis). The mean of four animals is
shown and the error bars indicate the standard deviation of this small population.

As with the phantom experiments the optical fiber was placed in the center of the beam.
Typical spectra are seen in Fig. 4(b) and the results from the fitting procedure are stated in
Fig. 4(c). As expected, after sacrifice, both the total hemoglobin concentration and
consequently the oxygenation decrease. The differences in spectral shapes between the
spectra from phantom experiments see Fig. 3(a), and in vivo experiments in Fig. 4(b) could be
attributed to several factors. First, the scattering is most likely higher in the animal tissue than
in the phantom solution making light from longer distances less likely to be detected.
Secondly, the phantom geometry is large compared to the animal size allowing light to
propagate throughout a larger volume. Thirdly, there might be other absorbers such as
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melanin in the skin that perturb the spectral shapes. The in vivo results presented here are
retrieved by calibrating the fitting procedure to a euthanized animal with assumed water
content prior to the data evaluation. The SO2 values were 31% +/− 5% and 0% +/− 1% for
normal respiration and after death, respectively. The hemoglobin values were 9 +/− 2
microMolar and 6 +/− 2 microMolar in the same two conditions. Clearly the hemoglobin
values were slightly lower than might be expected and the SO2 during anesthesia might be
lower than expected, although anesthesia with ketamine is known to reduce these values in
vivo. Validation with external measurements was not available, however the changes
expected before and after euthanasia were as expected here.
4. Discussion
The results presented in this work indicate that quantitative spectral analysis of Cherenkov
light is possible for emission generated by high-energy external beam radiation. The phantom
studies show that it is feasible to track changes of both total hemoglobin concentration and
hemoglobin oxygen saturation. The range of concentrations of hemoglobin and intralipid
where not chosen to be exhaustive here, but rather chosen to mimic the scattering and
hemoglobin values expected in mouse skin. The in vivo study further demonstrates the
applicability where a clear change between pre- and post- euthanasia of the mice was
quantified using the method described here.
However, diffuse optical spectroscopy is non-unique meaning that several solutions exist
to the inverse problem that satisfies the minimization criterion. This is a predicament arising
from the fundamental property that light is diffusely scattered in tissue. Throughout this work
the scattering properties of the medium under study, i.e. scattering amplitude and scattering
power, have not been allowed to vary. In order to retrieve quantitative numbers for both
chromophores and scattering properties, the spectral region needs to be optimized. A spectral
interval at shorter wavelengths, e.g. between 480 and 650, seems to allow fitting of both
chromophore concentrations and scattering parameters [12]. On the other hand shorter
wavelengths make the method more sensitive to changes at shallow depths. In this work the
fiber is placed in the beam since minimal Cherenkov emission was induced in the fiber if the
angle between the beam and the fiber was 90°. However this setup makes the method mostly
sensitive to changes in the tissue surface. In order to provide a more volumetric measure of
the tissue oxygenation, more fibers are needed which could be easily added. The
spectroscopic evaluation presented herein would in that case expand to a tomographic
approach, see for example [23, 24]. Currently the optimal detector placement relative to the
beam as well as optimal spectral interval to perform the data analysis is being investigated.
The in-vivo results retrieved from the mice, pre- and post-sacrifice, indicate low
hemoglobin oxygen saturation. Normal mouse skin is thought to be fairly well oxygenated,
with published estimates near 75% [20]. However, the mice were anesthetized with
ketamine/xylazine, which suppresses blood flow as well as tissue oxygenation. It has been
reported that anesthesia using ketamine/xyalzine results in a drop of about 50% of the pO2 in
a mouse leg muscle [25]. According to the oxygen dissociation curve a drop in pO2 of 50%
corresponds to a decrease in hemoglobin oxygen saturation from 75% to around 30% [26].
Hence, the lower oxygen saturation retrieved in-vivo is quite reasonable. Validation of the
SO2 values and hemoglobin concentration was not possible at the time of this experiment, as
specialized instrumentation would be required to do this, however the values observed are
within plausible ranges of what could be expected in mouse skin tissue. Certainly the tissue
phantom data was indicative of reasonable values for nearly fully oxygenated solutions and
nearly fully deoxygenated solutions.
A low oxygen level in tumor tissue is a well-known prognostic marker for treatment
failure of cancer and great efforts are dedicated to monitor and target these regions. PET
imaging based on hypoxic markers [27, 28] can be used elegantly to reveal regions with
oxygen deficiency using exogenous probes administered to the patient, but has had limited
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clinical acceptance mostly due to cost. Cherenkov emission spectroscopy, as presented herein,
will likely not be used for diagnosing hypoxic regions, unless within a few centimeters from
the surface. However, the potential of the current method lies in treatment monitoring where
changes in tissue oxygenation are of ample interest and are more accessible. The major benfit
from Cherenkov light spectroscopy is the fact that the signal is inherently produced in all
tissues being irradiated and requires no injectable contrast. However clearly the limitations are
related to the penetration of the signal out of the volume being treated, or access by fiber
optics to the region. Future work pursuing the idea of real-time evaluation of tissue
oxygenation is warranted, and validation in tumor experiments with changes in tissue oxygen
levels during fractionated therapy is planned based on this endogenous optical signal.
5. Conclusions
The demonstrated CES methodology provides the ability for quantitative analysis of
hemoglobin concentration and oxygen saturation during external beam radiation therapy, as
verified by tissue phantoms. The method utilizes the intrinsically generated Cherenkov
radiation that is passively emitted from all tissue during radiation therapy. Preliminary in vivo
testing has demonstrated that the values seen are plausible, and changes between living and
dead tissue are as should be expected. This method has potential for tissue oxygenation
monitoring during the course of standard fractionated radiation therapy treatments, thereby
providing an easily implemented prognostic biomarker of the treatment efficacy. Further work
must be done to quantitatively verify the estimation in vivo, using external correlates of tissue
SO2 and hemoglobin concentration, and this work is ongoing.
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